⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15828432 | 0.98 | SIGMAR1 (0.33) | — | |
| SCHEMBL2589239 | 0.95 | — | — | |
| SCHEMBL10458506 | 0.74 | CHRM5 (0.40) | — | |
| SCHEMBL14123791 | 0.70 | — | — | |
| SCHEMBL20719781 | 0.70 | — | — | |
| SCHEMBL11069 | 0.70 | — | — | |
| SCHEMBL19642817 | 0.69 | CYP2A6 (0.39) | — | |
| SCHEMBL10882 | 0.69 | — | — | |
| SCHEMBL15828458 | 0.67 | SIGMAR1 (0.33) | — | |
| SCHEMBL15828457 | 0.67 | FKBP5 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040254158-A1 | Anticoagulants; atherosclerosis; strokes; thrombosis; cardiovascular disorders | BRISTOL-MYERS SQUIBB COMPANY | 2004-12-16 | — | — | US | claimed |
| EP-1117661-B1 | PROPANOLAMINE DERIVATIVES SUBSTITUTED WITH HETEROCYCLIC COMPOUNDS, METHODS FOR THEIR PRODUCTION, PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUNDS AND THE USE THEREOF | AVENTIS PHARMA GMBH (DE) | 2004-05-26 | — | — | EP | claimed |
| EP-1117661-A1 | PROPANOLAMINE DERIVATIVES SUBSTITUTED WITH HETEROCYCLIC COMPOUNDS, METHODS FOR THEIR PRODUCTION, PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUNDS AND THE USE THEREOF | Aventis Pharma Deutschland GmbH (DE) | 2001-07-25 | — | — | EP | claimed |
| WO-2000020410-A1 | PROPANOLAMINE DERIVATIVES SUBSTITUTED WITH HETEROCYCLIC COMPOUNDS, METHODS FOR THEIR PRODUCTION, PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUNDS AND THE USE THEREOF | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2000-04-13 | — | — | WO | claimed |
| JP-59015934-A | — | — | None | — | — | JP | disclosed |
| EP-4688784-A1 | KRAS INHIBITORS | Eli Lilly and Company (US) | 2026-02-11 | — | — | EP | disclosed |
| US-20240343736-A1 | KRAS INHIBITORS | ELI LILLY AND COMPANY | 2024-10-17 | — | — | US | disclosed |
| WO-2024206747-A1 | KRAS INHIBITORS | ELI LILLY AND COMPANY (US) | 2024-10-03 | — | — | WO | disclosed |
| EP-4252755-A2 | THERAPEUTIC COMPOUNDS | C4x Discovery Limited (GB) | 2023-10-04 | — | — | EP | disclosed |
| WO-2023179366-A1 | OXADIAZOLE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF | 星希尔生物科技(上海)有限公司 | 2023-09-28 | — | — | WO | disclosed |
| EP-3870578-B1 | THERAPEUTIC COMPOUNDS | C4X DISCOVERY LTD (GB) | 2023-08-16 | — | — | EP | disclosed |
| US-20230159511-A1 | TETRAHYDROISOQUINOLINE COMPOUNDS AS NRF2 ACTIVATORS | C4X DISCOVERY LIMITED (GB) | 2023-05-25 | — | — | US | disclosed |
| US-6303639-B1 | FOR THERAPY AND PROPHYLAXIS OF HYPERLIPIDEMIA, ARTERIOSCLEROTIC SYMPTOMS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2001-10-16 | — | — | US | disclosed |
| EP-1117661-A1 | PROPANOLAMINE DERIVATIVES SUBSTITUTED WITH HETEROCYCLIC COMPOUNDS, METHODS FOR THEIR PRODUCTION, PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUNDS AND THE USE THEREOF | Aventis Pharma Deutschland GmbH (DE) | 2001-07-25 | — | — | EP | disclosed |
| EP-1035843-A2 | I h?-MODULATORS | Akzo Nobel N.V. (NL) | 2000-09-20 | — | — | EP | disclosed |
| US-6080773-A | USEFUL FOR TREATMENT OF DEPRESSION, ANXIETY OR PSYCHOSIS | AKZO NOBEL, N.V. (NL) | 2000-06-27 | — | — | US | disclosed |
| WO-2000020410-A1 | PROPANOLAMINE DERIVATIVES SUBSTITUTED WITH HETEROCYCLIC COMPOUNDS, METHODS FOR THEIR PRODUCTION, PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUNDS AND THE USE THEREOF | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2000-04-13 | — | — | WO | disclosed |
| WO-1999018941-A2 | Ih-MODULATORS | AKZO NOBEL N.V. (NL) | 1999-04-22 | — | — | WO | disclosed |
| US-5256672-A | Antipsychotic, analgesic | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1993-10-26 | — | — | US | disclosed |
| JP-S5915934-A | COLORED PHOTOSENSITIVE SILVER HALIDE MATERIAL | MITSUBISHI PAPER MILLS LTD | 1984-01-27 | — | — | JP | disclosed |